Actor Eric Dane, known for his roles inGrey's Anatomyand Euphoria, has died at the age of 53 following a battle with amyotrophic lateral sclerosis (ALS), his family confirmed. Dane's death on 19 February 2026 came less than a year after he publicly revealed his diagnosis, bringing global attention to a rare but devastating neurological disease. ALS is a progressive condition that affects nerve cells controlling voluntary muscle movement, leading to loss of function and, eventually, death.
ALS is a degenerative neurological disorder thattargets motor neurons in the brain and spinal cord, the cells responsible for transmitting signals that enable voluntary movement. When these neurons deteriorate, they can no longer communicate effectively with muscles. Over time this leads to muscle weakness and atrophy throughout the body. ALS is also commonly referred to as Lou Gehrig's disease, after the famous US baseball player who was diagnosed with it in the 1930s.
ALS usually begins subtly, often with weakness or stiffness in limbs or hands. As the disease progresses, affected individuals may experience difficulty walking, speaking clearly, swallowing, or breathing independently. The condition does not typically impair a person's senses or bladder control but can affect cognition in a subset of patients.
Early warning signs of ALScan include muscle weakness in a hand or leg, frequent tripping, slurred speech, or muscle cramps and twitching. These symptoms often gradually spread to other parts of the body as motor neurons continue to die. Patients may eventually lose the ability to stand, move their limbs without assistance, or perform basic daily tasks. Slowed or slurred speech can progress to complete loss of speech.
Breathing and swallowing difficulties emerge as the condition advances. Many people with ALS require feeding tubes when swallowing becomes unsafe, and ventilatory support becomes necessary when respiratory muscles weaken.
There is no one-size-fits-all timeline for ALS progression, but most people diagnosed with the disease live for an average of three to five years after symptoms appear. Around 20% to 30% may live five years or longer, and a smaller number survive a decade or more. Factors influencing life expectancy include the age at onset, the initial symptoms, and overall health.
The disease's course varies widely from person to person. Some experience rapid deterioration, while others maintain function for longer periods. Progression is generally steady, with increasing muscle weakness spreading to essential movements such as breathing and swallowing.
There is presently no cure for ALS, and no treatment can reverse the damage to motor neurons. However, several medications and supportive therapies aim to slow symptom progression and improve quality of life. The drugriluzole has been shown to extend survival modestly, whileedaravone may reduce the rate of functional decline. Other treatments focus on alleviating muscle cramps, managing emotional symptoms, and assisting breathing and nutrition as needs change.
Multidisciplinary care involving physiotherapists, occupational therapists, and respiratory specialists can help maintain independence for as long as possible. Experimental research continues worldwide, with studies exploring gene therapies and other innovative approaches to alter disease progression.
Dane revealed his diagnosis of ALS in April 2025, describing the early loss of function in his right arm and gradual spread to other parts of his body. He continued to work and advocate for awareness throughout his illness. His openness about the symptoms and progression of ALS helped spotlight the condition and the urgent need for research into effective treatments.
Source: International Business Times UK
